213 related articles for article (PubMed ID: 31307996)
1. Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
Chan DC; Pang J; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chem; 2019 Oct; 65(10):1258-1266. PubMed ID: 31307996
[TBL] [Abstract][Full Text] [Related]
2. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia.
Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B
J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882
[TBL] [Abstract][Full Text] [Related]
3. Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation.
Fatica EM; Meeusen JW; Vasile VC; Jaffe AS; Donato LJ
Clin Biochem; 2020 Dec; 86():45-51. PubMed ID: 32997972
[TBL] [Abstract][Full Text] [Related]
4. Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.
Chubykina UV; Ezhov MV; Afanasieva OI; Klesareva EA; Pokrovsky SN
Diseases; 2022 Jan; 10(1):. PubMed ID: 35225859
[TBL] [Abstract][Full Text] [Related]
5. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
[TBL] [Abstract][Full Text] [Related]
7. Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia.
Tromp TR; Ibrahim S; Nurmohamed NS; Peter J; Zuurbier L; Defesche JC; Reeskamp LF; Hovingh GK; Stroes ESG
Atherosclerosis; 2023 Jan; 365():27-33. PubMed ID: 36473758
[TBL] [Abstract][Full Text] [Related]
8. A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia.
Sun D; Cao YX; Li S; Guo YL; Wu NQ; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
Clin Cardiol; 2019 Oct; 42(10):988-994. PubMed ID: 31436336
[TBL] [Abstract][Full Text] [Related]
9. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
[TBL] [Abstract][Full Text] [Related]
10. Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
Rizos CV; Florentin M; Skoumas I; Tziomalos K; Rallidis L; Kotsis V; Athyros V; Skalidis E; Kolovou G; Garoufi A; Bilianou E; Koutagiar I; Agapakis D; Kiouri E; Antza C; Katsiki N; Zacharis E; Attilakos A; Sfikas G; Anagnostis P; Panagiotakos DB; Liberopoulos EN
Lipids Health Dis; 2020 May; 19(1):114. PubMed ID: 32466791
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
[TBL] [Abstract][Full Text] [Related]
12. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
[TBL] [Abstract][Full Text] [Related]
15. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF
J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959
[TBL] [Abstract][Full Text] [Related]
17. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
[TBL] [Abstract][Full Text] [Related]
18. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
[TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
Mortensen MB; Kulenovic I; Klausen IC; Falk E
J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
[TBL] [Abstract][Full Text] [Related]
20. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
